The latest trading day saw Bristol Myers Squibb (BMY) settling at $56.29, representing a -0.16% change from its previous close.
The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...
Jefferies has recently raised Bristol-Myers Squibb Co (BMY) stock to Buy rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the ...
Brill Power has launched the world’s first Battery Management as a Service (BMaaS) offering to maximize the performance of ...